Biodesix Inc (BDSX): who owns it and who trades it
As of Nov 16, 2026, BDSX insiders reported 12 open-market sales worth $104K and 7 purchases worth $4.1M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Scott Hutton (CEO), with $62.8K. 3 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Biodesix
From the latest filingsOverall: more buying than selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns BDSX
44 funds and institutions reported BDSX shares worth $92.1M at the end of Q2 2026, about 40% of the company. The largest holder is AIGH Capital Management LLC with 6.7%.
Funds and institutions (13F) 40%Everyone else 60%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| AIGH Capital Management LLC | 678,328 | 6.71% | $15.3M | -11% |
| Soleus Capital Management, L.P. | 585,958 | 5.80% | $13.2M | +41% |
| Telemark Asset Management, LLC | 489,824 | 4.85% | $11M | No change |
| Aberdeen Group plc | 388,639 | 3.84% | $8.8M | -15% |
| Vanguard Capital Management LLC | 284,169 | 2.81% | $6.4M | +11% |
| Essex Investment Management Co LLC | 241,915 | 2.39% | $5.5M | +83% |
| Opaleye Management Inc. | 180,000 | 1.78% | $4.1M | -24% |
| Marshall Wace, LLP | 116,199 | 1.15% | $2.6M | -18% |
| Perceptive Advisors LLC | 108,694 | 1.08% | $2.5M | New |
| Jane Street Group, LLC | 91,506 | 0.91% | $2.1M | +239% |
| Two Sigma Investments, LP | 86,824 | 0.86% | $2M | +92% |
| Legato Capital Management LLC | 81,381 | 0.81% | $1.8M | +98% |
| Walleye Capital LLC | 74,447 | 0.74% | $1.7M | +587% |
| Stempoint Capital LP | 70,000 | 0.69% | $1.6M | -50% |
| Geode Capital Management, LLC | 67,657 | 0.67% | $1.5M | +35% |
| Trexquant Investment LP | 57,972 | 0.57% | $1.3M | -17% |
| Gsa Capital Partners LLP | 46,989 | 0.46% | $1.1M | +19% |
| Perkins Capital Management Inc | 44,618 | 0.44% | $1M | -0% |
| BlackRock, Inc. | 43,026 | 0.43% | $970K | +76% |
| Blair William & Co | 41,548 | 0.41% | $937K | +51% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, BDSX insiders reported $4.1M of open-market purchases and $104K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Jack W Schuler | 10% owner | Purchase | 100,000 | $10.02 | $1M | Form 4 |
| Aug 12, 2026 | Jack W Schuler | 10% owner | Purchase | 15,000 | $24.47 | $367K | Form 4 |
| Aug 11, 2026 | Jack W Schuler | 10% owner | Purchase | 13,700 | $24.01 | $329K | Form 4 |
| Aug 10, 2026 | Jack W Schuler | 10% owner | Purchase | 13,900 | $24.25 | $337K | Form 4 |
| Feb 23, 2026 | Scott Hutton | CEO | Sale | 1,490 | $12.78 | $19K | Form 4 |
| Feb 23, 2026 | Chris Vazquez | Chief Accounting Officer | Sale | 211 | $12.78 | $2.7K | Form 4 |
| Feb 23, 2026 | Gary Anthony Pestano | Chief Development Office | Sale | 556 | $12.78 | $7.1K | Form 4 |
| Feb 23, 2026 | Kieran O'Kane | Chief Commercial Officer | Sale | 535 | $12.78 | $6.8K | Form 4 |
| Feb 10, 2026 | Chris Vazquez | Chief Accounting Officer | Sale | 101 | $10.08 | $1K | Form 4 |
| Feb 10, 2026 | Scott Hutton | CEO | Sale | 3,559 | $10.08 | $35.9K | Form 4 |
| Feb 10, 2026 | Kieran O'Kane | Chief Commercial Officer | Sale | 584 | $10.08 | $5.9K | Form 4 |
| Feb 10, 2026 | Gary Anthony Pestano | Chief Development Office | Sale | 540 | $10.08 | $5.4K | Form 4 |
| Feb 10, 2026 | Robin Harper Cowie | CFO | Sale | 941 | $10.08 | $9.5K | Form 4 |
| Jan 26, 2026 | Jack W Schuler | 10% owner | Purchase | 20,000 | $11.80 | $236K | Form 4 |
| Jan 23, 2026 | Jack W Schuler | 10% owner | Purchase | 80,000 | $11.81 | $945K | Form 4 |
| Jan 22, 2026 | Jack W Schuler | 10% owner | Purchase | 82,465 | $10.96 | $904K | Form 4 |
| Jan 16, 2026 | Chris Vazquez | Chief Accounting Officer | Sale | 83 | $8.15 | $676 | Form 4 |
| Jan 16, 2026 | Gary Anthony Pestano | Chief Development Office | Sale | 298 | $8.15 | $2.4K | Form 4 |
| Jan 16, 2026 | Scott Hutton | CEO | Sale | 970 | $8.15 | $7.9K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Jack W Schuler | 10% owner | $4.1M | – | Nov 10, 2026 |
| Scott Hutton | President & CEO, Director | – | $62.8K | Feb 23, 2026 |
| Gary Anthony Pestano | Chief Development Officer | – | $15K | Feb 23, 2026 |
| Kieran O'Kane | Chief Commercial Officer | – | $12.7K | Feb 23, 2026 |
| Robin Harper Cowie | CFO, Sec'y & Treasurer | – | $9.5K | Feb 10, 2026 |
| Chris Vazquez | Chief Accounting Officer | – | $4.4K | Feb 23, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
BDSX short interest
Low short interest. 1.9% of BDSX shares are sold short: about 1 share in 53. Over the last 12 reports the number of shares short went up 53%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 210,018 BDSX shares were sold short, 1.9% of the shares outstanding, up 0.2% from the report before. At the average daily volume of 85,505 shares, buying them all back would take about 2.5 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 210,018 | 1.89% | +0% | 85,505 | 2.5 |
| Oct 15, 2026 | 209,504 | 1.99% | +4% | 89,325 | 2.4 |
| Sep 30, 2026 | 201,849 | 1.91% | -6% | 109,841 | 1.8 |
| Sep 15, 2026 | 214,006 | 2.03% | -3% | 64,993 | 3.3 |
| Aug 31, 2026 | 220,383 | 2.09% | +47% | 166,058 | 1.3 |
| Aug 14, 2026 | 150,085 | 1.42% | -5% | 94,816 | 1.6 |
| Jul 31, 2026 | 157,187 | 1.49% | -6% | 58,674 | 2.7 |
| Jul 15, 2026 | 167,970 | 1.66% | +59% | 76,533 | 2.2 |
| Jun 30, 2026 | 105,427 | 1.04% | +1% | 125,490 | 1.0 |
| Jun 15, 2026 | 104,666 | 1.04% | -2% | 39,919 | 2.6 |
| May 29, 2026 | 106,463 | 1.05% | -22% | 46,923 | 2.3 |
| May 15, 2026 | 137,196 | 1.36% | -7% | 101,631 | 1.4 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Biodesix company events
Biodesix filed 7 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026LeadershipIt was agreed that the employment of Kieran O’Kane, Chief Commercial Officer of Biodesix, Inc. would end effective November 2, 2026. Filing
- Nov 5, 2026ResultsReleased financial results. Filing
- Aug 5, 2026ResultsReleased financial results. Filing
- May 20, 2026VoteReported shareholder vote results. Filing
- May 4, 2026ResultsReleased financial results. Filing
- Feb 26, 2026ResultsReleased financial results. Filing
- Jan 12, 2026ResultsAmended an earlier report. Released financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Biodesix financials
Famous investors that hold BDSX
3 of the 50 well-known investors we track reported holding BDSX in their latest 13F filing. The largest position is Israel Englander's, worth $3.4M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 114,666 | $3.4M | 0.0% | +696% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 34,259 | $1M | 0.0% | New |
| Jim Simons · Renaissance Technologies | Q3 2026 | 32,348 | $965K | 0.0% | +13% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named BDSX in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 12, 2026 | SCHULER JACK W | 13D/A | 22.3% |
| Nov 12, 2026 | SCHULER JACK W | 13D/A | 22.3% |
Questions about Biodesix Inc (BDSX) stock
Who owns the most BDSX stock?
The largest reported owner of Biodesix Inc (BDSX) is AIGH Capital Management LLC, with 6.7% of the company. In total, 44 funds and institutions reported holding BDSX at the end of Q2 2026, together about 40% of the shares. See the largest owners.
Are BDSX insiders buying or selling?
In the last 12 months, BDSX insiders reported 7 open-market purchases worth $4.1M and 12 sales worth $104K. The latest trade was on Nov 10, 2026. See every trade.
What is the short interest in BDSX?
As of Oct 30, 2026, 210,018 BDSX shares were sold short, 1.9% of the shares outstanding, up 0.2% from the report before. At the average daily volume of 85,505 shares, buying them all back would take about 2.5 trading days (days to cover). See the history.
Which famous investors hold BDSX?
3 of the 50 well-known investors we track reported BDSX in their latest 13F filing, including Israel Englander, Ken Griffin, Jim Simons. The largest position is worth $3.4M. See all holders.
Executive pay
Biodesix's chief executive was paid a total of $2.2M for the year ended Dec 31, 2025, up 7% from $2.1M the year before. In the last 12 months, Biodesix's executives and directors bought no stock on the open market and sold $104K.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.